Trials

  • May 22, 2026

    EDTX Jury Awards $3.3M In Battery Components Patent Trial

    A jury in the Eastern District of Texas found Friday that South Korean company Solus Advanced Materials Co. Ltd. owes almost $3.3 million for infringing a rival's patents tied to copper foils used for batteries.

  • May 22, 2026

    Google Urges DC Circ. To Nix DOJ's Search Win

    Google told the D.C. Circuit Friday the government is using antitrust law to punish a successful competitor as it looks to overturn a trial court's ruling finding that Google illegally maintained its search monopoly.

  • May 22, 2026

    Prosecutors Seek $1.98M Forfeiture In Goldstein Case

    Federal prosecutors are seeking a nearly $2 million forfeiture judgment against convicted SCOTUSblog founder Tom Goldstein and asking a Maryland federal judge to turn the Supreme Court lawyer's Northwest D.C. home over to the government to pay it.

  • May 21, 2026

    OpenAI Ouster About Governance, Not Bad Counsel, Pros Say

    Witness testimony offered during a recent high-profile jury trial over Elon Musk's challenge to OpenAI's for-profit restructuring accused the artificial intelligence company's nonprofit board of following bad legal advice when it fired CEO Sam Altman in 2023, although experts say the incident was more likely the product of poor governance rather than lousy legal counsel.

  • May 21, 2026

    Citron Founder's Tweets Impacted Stock Prices, LA Jury Told

    A former U.S. Securities and Exchange Commission financial economist testified Thursday in the criminal securities fraud case against Citron Research founder Andrew Left, telling a California federal jury that allegedly deceptive tweets posted by the "activist investor" clearly had a "statistically significant" impact on companies' stock prices.

  • May 21, 2026

    Meta Expert Says $27M Is Better Number For Abatement

    An economics expert for Meta testified Thursday against New Mexico's desired $3.7 billion plan to abate social media's harm to mental health, calling it more "a spending plan" than one for abatement and claiming $27 million will do the job.

  • May 21, 2026

    J&J Used Ellipsis To Nix Asbestos In Report To FDA, Jury Told

    Johnson & Johnson used an ellipsis to eliminate a professor's finding of asbestos in its talc in a report submitted to the U.S. Food and Drug Administration, according to a video deposition shown Thursday to a California jury considering bellwether claims over three women's deadly ovarian cancer.

  • May 21, 2026

    9th Circ. Says Judge Overstepped In Fluoride Risk Case

    A Ninth Circuit panel scrapped a ruling that directed the U.S. Environmental Protection Agency to take action to address potentially unsafe levels of drinking water fluoridation, concluding a California federal judge improperly commandeered the case.

  • May 21, 2026

    Insurer Can't Nix Counterclaims In $1.8M Judgment Dispute

    A North Carolina federal judge found that a life sciences company's insurer can't avoid counterclaims brought by a former patent holder asserting that the carrier must cover a $1.77 million judgment entered against the company's executives after they were accused of making misrepresentations about taking the company public.

  • May 21, 2026

    LGBCoin Buyers Say Sanctions Bid Flunks Safe Harbor Rule

    Investors in the "Let's Go Brandon" meme coin asked a Florida federal court to reject a sanctions bid filed by the coin's founder, saying he didn't comply with the court's safe harbor rule requiring him to send a draft motion 21 days in advance. 

  • May 21, 2026

    UCB Staves Off Seizure Drug Competition After Bench Trial

    UCB Inc. has persuaded a Delaware federal judge to uphold patents covering its seizure medication Nayzilam, a major win given that generic-drug maker Cipla Ltd. already admitted to infringement.

  • May 21, 2026

    9th Circ. Told To Reject J&J Unit's $442M Antitrust Appeal

    Cardiac catheter refurbisher Innovative Health urged the Ninth Circuit to reject the appeal from Johnson & Johnson's Biosense Webster unit seeking to upend its $442 million antitrust judgment, saying the lower court rightly found that Biosense forced hospitals to avoid refurbished catheters in favor of its own.

  • May 21, 2026

    Jury Can See Inside ICE Facility, Judge Says

    A Colorado federal judge ordered Thursday that jurors be permitted to view the inside of an immigration detention facility near Denver, agreeing with detainees that visiting the GEO Group Inc.-operated facility will help them better understand key issues in the detainees' human trafficking class action.

  • May 21, 2026

    Baltimore Atty Not Liable For Client's Taxes, 4th Circ. Told

    A Baltimore attorney is challenging a court's order that he cover unpaid federal income taxes owed by his client's holding company, telling the Fourth Circuit on Thursday that the government is wrongly using the Federal Priority Statute as a workaround for the Federal Tax Lien Act.

  • May 21, 2026

    Del. Jury Awards AI Co. $23M In Trade Secret Case

    A Delaware state jury has awarded artificial intelligence software developer C3.ai $23.3 million in its suit accusing engine manufacturer Cummins Inc. of misappropriating its trade secrets.

  • May 21, 2026

    Medical Practice Calls $49M Missed Cancer Verdict 'Unjust'

    The Westchester Medical Group PC has asked a Connecticut state judge to find most of a $49 million jury verdict "excessive, unjust, and entirely disproportionate" to claims its staff repeatedly failed to diagnose cancer despite multiple warning signs, calling the award punitive and not supported by the evidence.

  • May 21, 2026

    Meta, Others Settle Bellwether School Case Set For June Trial

    Meta Platforms Inc., Snap Inc., TikTok Inc. and YouTube have each agreed to settle a bellwether school district's claims in social media addiction multidistrict litigation that were set for a six-week California federal jury trial beginning June 12, according to the Kentucky school district's counsel.

  • May 21, 2026

    Fed. Circ. Backs Lupin Win In Generic Kidney Drug Case

    The Federal Circuit on Thursday affirmed a Delaware federal judge's ruling that Indian generic-drug maker Lupin's version of the kidney disease drug Jynarque does not infringe two patents held by Japanese rival Otsuka.

  • May 21, 2026

    2nd Circ. Agrees Amazon Not Liable In Fur Import Evasion

    A U.S. fur company couldn't show that Amazon willfully ignored a 15-year scheme carried out by foreign fur sellers to avoid certain tariffs and import fees, a Second Circuit panel found, affirming the dismissal of a False Claims Act suit against the company.

  • May 21, 2026

    How Exxon Attys Beat A 10-Year-Old Securities Class Action

    This month, Exxon Mobil's defense team helped deliver a clean sweep victory for the energy giant when a federal jury in Texas found the company did not lie to investors about the profitability of some operations.

  • May 21, 2026

    Baker Donelson Found At Fault In Miss. Timber Ponzi Suit Trial

    A Mississippi federal jury has found that Baker Donelson Bearman Caldwell & Berkowitz PC committed negligent supervision as part of a mixed verdict in a trial over claims the firm allowed a timber company's nine-figure Ponzi scheme to unfold under its nose.

  • May 21, 2026

    Ga. Panel Says Trial Court Wrongly Denied New Med Mal Trial

    A Georgia appeals panel has sent a man's malpractice suit back to trial court, finding the lower court judge wrongly denied his motion for a new trial when he determined that the jury was required to decide whether gross negligence standards applied to the case.

  • May 20, 2026

    Prof. Hired By J&J In 1970s Found Asbestos In Talc, Jury Told

    A former Johnson & Johnson toxicologist could not find evidence his employer turned over a report to the U.S. Food and Drug Administration that "unmistakably" found asbestos in the company's talc, according to a video deposition shown Wednesday to a California jury considering bellwether claims over three women's deadly ovarian cancer.

  • May 20, 2026

    Top 4 Most Surprising Moments In Musk-OpenAI Trial

    The high-profile trial over Elon Musk's challenge to OpenAI's for-profit conversion wrapped Monday with a quick jury verdict in favor of OpenAI and its executives, but the three-week trial drew some surprising moments for those in the courtroom who had front row seats to the fight between billionaires.

  • May 20, 2026

    Social Media Not Proven To Harm Mental Health, Judge Told

    A statistics expert for Meta sought Wednesday to undermine the claim that social media has driven a rise in mental health conditions among teens, saying the New Mexico attorney general's key witness on the topic didn't consider alternative factors like widening access to mental health care.

Expert Analysis

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • Opinion

    Judges Carry Onus To Screen Expert Opinions Before Juries

    Author Photo

    Recent Second Circuit arguments in Acetaminophen Products Liability Litigation implied a low bar for judicial gatekeeping of expert testimony, but under amended Rule 702 of the Federal Rules of Evidence, judges must rigorously scrutinize expert opinions before allowing them to reach juries, says Lee Mickus at Evans Fears.

  • 4 California Insurance Law Decisions To Know From 2025

    Author Photo

    California continued to shape the national insurance landscape in 2025, issuing a series of decisions that may recalibrate claims handling, underwriting strategy and policy drafting in areas from property damage claims after a wildfire to automobile coverage for delivery drivers in the gig economy, say attorneys at Nicolaides Fink.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • 7 Strategies To Optimize Impact Of Direct Examination

    Author Photo

    Direct examination is a make-or-break opportunity to build a witness’s credibility, so attorneys should adopt a few tactics — from asking so-called trust-fall questions to preemptively addressing weaknesses — to drive impact and retention with the fact-finder, says Allison Rocker at Baker McKenzie.

  • Series

    Nature Photography Makes Me A Better Lawyer

    Author Photo

    Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.

  • Series

    Law School's Missed Lessons: Practical Problem Solving

    Author Photo

    Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.

  • Reel Justice: 'The Mastermind' And Juror Decision-Making

    Author Photo

    The recent art heist film “The Mastermind” forces viewers to discern the protagonist’s ambiguous motives and reconcile contradictions, offering lessons for attorneys about how a well-crafted trial narrative can tap into the psychological phenomena underlying juror decision-making, says Veronica Finkelstein at Wilmington University.

  • Opinion

    A Uniform Federal Rule Would Curb Gen AI Missteps In Court

    Author Photo

    To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.

  • 3 Defense Strategies For Sporadically Prosecuted Conduct

    Author Photo

    Not to be confused with selective prosecutions, sporadic prosecutions — charging someone for conduct many others do without consequences — can be challenging to defend, but focusing on materiality, prosecutorial motivations and public opinion can be a winning strategy, says Jonathan Porter at Husch Blackwell.

  • Series

    The Law Firm Merger Diaries: Integrating Practice Groups

    Author Photo

    Enacting unified leadership and consistent client service standards ensures law firm practice groups connect and collaborate around shared goals, turning a law firm merger into a platform for growth rather than a period of disruption, says Brian Catlett at Fennemore Craig.

  • Tapping Into Jurors' Moral Intuitions At Trial

    Author Photo

    Many jurors approach trials with foundational beliefs about fairness, harm and responsibility that shape how they view evidence and arguments, so attorneys must understand how to frame a case in a way that appeals to this type of moral reasoning, says Steve Wood at Courtroom Sciences.

  • Patent Disclaimers Ruling Offers Restriction Practice Insights

    Author Photo

    The Federal Circuit's recent decision in Focus Products v. Kartri confirms that prosecution disclaimers can extend to examiner-defined species in restriction practice, making it important for patent practitioners to manage restriction requirement responses carefully to avoid unintended claim scope limitations, say attorneys at BCLP.

  • Opinion

    Supreme Court Term Limits Would Carry Hidden Risk

    Author Photo

    While proposals for limiting the terms of U.S. Supreme Court justices are popular, a steady stream of relatively young, highly marketable ex-justices with unique knowledge and influence entering the marketplace of law and politics could create new problems, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Trials archive.